Jean L. Nakamura

University of California, San Francisco

Papers

1

Total Citations

55

H-Index

1

About

Dr. Jean L. Nakamura is a leading radiation oncologist whose research focuses on advancing precision radiotherapy for cancer treatment, particularly for brain and prostate malignancies. Her major contributions center on evaluating and optimizing cutting-edge technologies to improve clinical outcomes. In her highly cited 2015 study (55 citations), Dr. Nakamura investigated the clinical advantages of a robotic linear accelerator equipped with a multileaf collimator (MLC), specifically the CyberKnife system. This pivotal work demonstrated the system’s enhanced performance for both stereotactic body radiotherapy (SBRT) and standard fractionated intensity-modulated radiotherapy (IMRT) in treating prostate and intracranial cancer patients. By systematically comparing treatment plans and delivery accuracy, she provided critical evidence supporting the adoption of MLC-equipped robotic systems, which allow for more precise tumor targeting while sparing healthy tissue. Her research has directly influenced clinical protocols, helping to reduce treatment side effects and improve patient quality of life. Dr. Nakamura’s work bridges engineering innovation and patient care, making her a respected voice in the field of radiation oncology and a key contributor to the evolution of non-invasive cancer therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Investigating the clinical advantages of a robotic linac equipped with a multileaf collimator in the treatment of brain and prostate cancer patients
55 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago